Melissa M Batt1,2,3, Aviva K Olsavsky4,5, Shaleah Dardar6,5, Celeste St John-Larkin6,5, Rachel L Johnson7, Mary D Sammel7. 1. Department of Psychiatry, University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, CO, USA. melissa.batt@cuanschutz.edu. 2. Helen and Arthur E. Johnson Depression Center, University of Colorado School of Medicine - Anschutz Medical Campus, 13199 East Montview Blvd, Suite 330, Aurora, CO, 80045, USA. melissa.batt@cuanschutz.edu. 3. Children's Hospital Colorado, Aurora, CO, USA. melissa.batt@cuanschutz.edu. 4. Departments of Psychiatry and Obstetrics/Gynecology, University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, CO, USA. 5. Children's Hospital Colorado, Aurora, CO, USA. 6. Department of Psychiatry, University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, CO, USA. 7. Department of Biostatistics & Informatics, CO School of Public Health - Anschutz Medical Campus, Aurora, CO, USA.
Abstract
PURPOSE OF REVIEW: The perinatal period is a time of increased vulnerability for people with bipolar disorder (BD). The purpose of this review is to provide an update of the literature from the last 3 years regarding course of illness and treatments for BD in the perinatal period to guide clinical care. RECENT FINDINGS: Postpartum manic and depressive episodes are emerging as having a unique presentation that may differentiate them from non-perinatal mood episodes. Many important updates regarding medication treatment in the perinatal period have been published recently that have considered the risks of untreated illness versus treatment risks in this population.' Despite significant research, there are still gaps in knowledge regarding safety and efficacy of medications for the mother and child. Crucial future areas of study include improved screening guidelines, randomized controlled trials examining medication safety in pregnancy and lactation, and efficacy of nonpharmacologic treatments.
PURPOSE OF REVIEW: The perinatal period is a time of increased vulnerability for people with bipolar disorder (BD). The purpose of this review is to provide an update of the literature from the last 3 years regarding course of illness and treatments for BD in the perinatal period to guide clinical care. RECENT FINDINGS: Postpartum manic and depressive episodes are emerging as having a unique presentation that may differentiate them from non-perinatal mood episodes. Many important updates regarding medication treatment in the perinatal period have been published recently that have considered the risks of untreated illness versus treatment risks in this population.' Despite significant research, there are still gaps in knowledge regarding safety and efficacy of medications for the mother and child. Crucial future areas of study include improved screening guidelines, randomized controlled trials examining medication safety in pregnancy and lactation, and efficacy of nonpharmacologic treatments.
Authors: Elisabetta Patorno; Krista F Huybrechts; Brian T Bateman; Jacqueline M Cohen; Rishi J Desai; Helen Mogun; Lee S Cohen; Sonia Hernandez-Diaz Journal: N Engl J Med Date: 2017-06-08 Impact factor: 91.245
Authors: Richard Wesseloo; Astrid M Kamperman; Trine Munk-Olsen; Victor J M Pop; Steven A Kushner; Veerle Bergink Journal: Am J Psychiatry Date: 2015-10-30 Impact factor: 18.112
Authors: Julia C Schechter; Patricia A Brennan; Alicia K Smith; Zachary N Stowe; D Jeffrey Newport; Katrina C Johnson Journal: J Abnorm Child Psychol Date: 2017-02
Authors: Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk Journal: Bipolar Disord Date: 2018-03-14 Impact factor: 6.744
Authors: D Jeffrey Newport; Adele C Viguera; Aquila J Beach; James C Ritchie; Lee S Cohen; Zachary N Stowe Journal: Am J Psychiatry Date: 2005-11 Impact factor: 18.112
Authors: Diana I Simeonova; Ashraf M Attalla; Theresa Nguyen; Emily Stagnaro; Bettina T Knight; W Edward Craighead; Zachary N Stowe; D Jeffrey Newport Journal: J Child Adolesc Psychopharmacol Date: 2014-12 Impact factor: 2.576
Authors: Sonia Hernandez-Diaz; Krista F Huybrechts; Rishi J Desai; Jacqueline M Cohen; Helen Mogun; Page B Pennell; Brian T Bateman; Elisabetta Patorno Journal: Neurology Date: 2017-12-27 Impact factor: 9.910
Authors: Javier Conejo-Galindo; Alejandro Sanz-Giancola; Miguel Ángel Álvarez-Mon; Miguel Á Ortega; Luis Gutiérrez-Rojas; Guillermo Lahera Journal: J Clin Med Date: 2022-07-08 Impact factor: 4.964